Select login type
xCHOOSE A PAGE TO ACCESS
x- WGXVI Development Safety Update Report Working Group Documents
- Pharmacoepidemiology for Public Health Working Group Documents
- WGXII Benefit-risk Working Group Documents
- Good Governance Practice for Research Institutions Working Group Documents
- Educational Standards Working Group Documents
- SCAR Working Group Documents
- WGXIII Real-world Data Working Group Documents
- WGXII Benefit-risk Working Group Documents
- MedDRA Labelling Groupings Working Group Documents
- WGXI Patient Involvement: Workplans, drafts, TC notes ...
- WGXI Patient Involvement: Background Documents
- WGXI Patient Involvement: Face-to-face meetings
- Clinical Research in Resource-limited Settings Working Group Documents
- Login
Statements made by the World Medical Association (WMA) on behalf of WMA and CIOMS during the 71st World Health Assembly
- Home
- Statements made by the World Medical Association (WMA) on behalf of WMA and CIOMS during the 71st World Health Assembly
The following statements were made by the World Medical Association (WMA) on behalf of WMA and CIOMS during the 71st World Health Assembly (21-26 May 2018) in Geneva:
11.5 Addressing the global shortage of and access to medicines and vaccines_20180516